Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | |
| Sales | 3,252 |
| Cost of Goods | 1,013 |
| Gross Profit | 2,239 |
| Operating Expenses | 4,596 |
| Operating Income | -2,344 |
| Interest Expense | 744 |
| Other Income | 164 |
| Pre-tax Income | -2,924 |
| Income Tax | 61 |
| Net Income Continuous | -2,985 |
| Net Income | $-2,985 |
| EPS Basic Total Ops | -59,693.40 |
| EPS Basic Continuous Ops | -59,700.00 |
| EPS Diluted Total Ops | -59,693.40 |
| EPS Diluted Continuous Ops | -59,700.00 |
| EBITDA(a) | $-2,344 |